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Classic viral pathogenesis models postulate that tissues supporting efficient virus replication promote virus
dissemination, which culminates in clinical illness. In this issue ofCell Host &Microbe, Sacher and colleagues
use Cre/loxP recombination to label murine cytomegalovirus during replication in distinct cell types in vivo.
Strikingly, they demonstrate that the most productive cell type in the host—the hepatocyte—contributes no
progeny to dissemination to other tissues.Successful viruses rarely stay put after
entering their host. Initial replication at
epithelial sites leads to viremic spread to
internal organs, where viral replication is
robust. A secondary, higher-level viremia
permits widespread dissemination to tis-
sues where disease becomes clinically
manifest. This textbook model of viral
spread was proposed by Fenner to de-
scribe mouse pox pathogenesis, but it
has received broad support in other
systems, including varicella zoster virus,
cytomegalovirus (CMV), measles, poliovi-
rus, and smallpox (Fenner, 1949).
Fenner’s model is descriptive—derived
by quantitating virus in organs over time—
yet it is often interpreted mechanistically.
For example, it is assumed that second-
ary viremia originates from organs repli-
cating virus to high titer (often the liver
and spleen), such that organs producing
the most virus contribute most signifi-
cantly to dissemination. However, Sacher
et al. challenge such an intuitive interpre-
tation of virus spread in this issue of Cell
Host & Microbe (Sacher et al., 2008b). In
the case of murine CMV (MCMV), high-
level replication in an organ does not
necessarily translate into systemic spread
originating from that organ. The authors
conclusively demonstrate that the most
productive site of virus replication in the
host—the liver—contributes no progeny
to secondary viremia.
MCMV is related to humanCMV, a ubiq-
uitous herpesvirus and a significant cause
of disease in neonates and immune com-
promised patients (Mocarski et al., 2007).
During natural infection, MCMV replicates
submucosally and spreads to internal
organs through the blood. Replication inmultiple organs, including liver, lung,
spleen, and kidney, is followedby second-
ary viremia and systemic disease. Like its
human counterpart, MCMV exhibits tro-
pism for both vascular endothelial cells
(EC) and hepatocytes (Hc) in vivo. The rel-
ative contribution of these twocell types to
primary infection and secondary viremia
was unclear prior to this study.
Sacher et al. (2008b) engineeredMCMV
to express EGFP only after a transcrip-
tional stop is removed by Cre-mediated
recombination. When this virus was used
to infect mice expressing Cre only in EC
(Tie2-cre), the majority of virus isolated
from most organs (with liver and kidney
as notable exceptions) expressed EGFP,
and this EC-derived virus was the
predominant contributor to secondary
viremia. This constitutes the first clear
evidence of a direct role for EC in CMV
pathogenesis.
In striking contrast, following infection
of mice expressing Cre in Hc (Albumin-
cre), the majority of virus in liver
expressed EGFP, but virus in all other
organs and blood had not undergone
recombination. Thus, although both EC
and Hc are direct targets for infection
during primary viremia, Hc replication
contributes no progeny to downstream
infection. These observations are all the
more enigmatic considering the authors’
calculation that greater than 90 percent
of total virus replication occurs in the liver.
This report uncovers a second intrigu-
ing aspect of the unique relationship
between Hc and MCMV: not only is
Hc-derived MCMV incapable of exiting
the liver, there is a limited window during
which MCMV can enter this site. OnceCell Host & Mprimary viremia has seeded Hc infection,
circulating, EC-derived virus could not
establish infection in the liver. So Hc serve
neither as producers nor targets of
secondary viremia. The authors speculate
that the brisk innate immune response
initiated in the liver shortly after infection
prevents superinfection (Mocarski et al.,
2007). This mechanism seems plausible
and may also contribute to the inability
of Hc-derived virus to seed other organs,
but seems unlikely to explain the dramatic
failure of Hc-derived MCMV to contribute
to viremia. The role of the innate immune
response in preventing Hc-targeted su-
perinfection could be addressed in inter-
feron-receptor-deficient, Tie2-cre mice
(Mu¨ller et al., 1994).
Why is the Hc an apparent dead-end
cell for MCMV? The authors eliminate
some important potential mechanisms:
the cellular immune response does not
prevent Hc-derived viremia, since even
overwhelming immune suppression did
not permit spread of Hc-derived virus.
Chemical disruption of liver endothelium
did not allow escape of virus from the
liver. Hc-derived virus seems capable of
limited spread within the liver and can ini-
tiate apparently normal infection in a naive
host. Thus, neither immune or endothelial
barriers, nor absolute spread defects
seem to prevent Hc-derived virus from
leaving the liver.
A recent manuscript from this group
suggests one explanation for the dead-
end nature of the Hc in MCMV: replication
of MCMV in Hcmay lead to apoptosis and
sequestration of infected cells (and their
viral progeny)by liver-residentphagocytes
(Cicin-Sain et al., 2008). Alternatively, theicrobe 3, April 2008 ª2008 Elsevier Inc. 201
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may hold potential clues.Hc are polarized,
with one surface facing the blood-filled
sinusoids and another facing the bile
canaliculi. Secretion of bile takes place
across the latter, while secretion of liver-
derived endocrine products proceeds
into the sinusoids. MCMV egress from Hc
may be polarized, with virions directed
predominantly toward the bile duct sys-
tem. While such a route would seem dis-
advantageous to an enveloped virus (due
to the detergent properties of bile), there
is evidence that some herpesviruses sur-
vive thegastrointestinal tract andestablish
infection in intestinal epithelium (Peacock
and Bost, 2000). A potential role for this
pathway in MCMV spread should be
experimentally addressed.
If the major source of viral replication
does not contribute to secondary viremia,
which cells do? Clearly, virus present
during secondary viremia has undergone
prior recombination in EC, but it is not
clear whether EC serve as the immediate
precursors of secondary viremia. Addi-
tional tissue-specific cre transgenic mice
will be required to identify these cell types.
Given their proposed roles in replication
and dissemination of CMV, epithelial
cells, monocytes, and dendritic cells
would be important cell types to address
in this respect (Mocarski et al., 2007).
Tissue-specific Cre-mediated deletion of
viral replication genes could define cell202 Cell Host & Microbe 3, April 2008 ª2008types necessary for secondary viremia.
Finally, it may be feasible to combine Cre-
mediated reporter activation with distinct
genetic approaches, such as Flp/FRT re-
combination, to sequentially label viruses
as they replicate in multiple tissues over
time (Feil, 2007).
The current manuscript focuses on
acute MCMV infection. Herpesvirus infec-
tion culminates in viral latency, a nonrepli-
cating state that serves to evade the
immune response and provide a lifelong
reservoir of virus that permits spread to
a new host following reactivation. The
findings of Sacher et al. suggest creative
genetic approaches to address funda-
mental unanswered questions in her-
pesvirus latency. Are latent infections
established at a defined step in infection,
or continuously during the life of the
host? What is the source of virus that
establishes latency? Do all tissues that
contribute to latent reservoirs participate
equally in virus spread to the next host?
The techniques used in this report, modi-
fied to allow for drug-inducible control of
virus labeling, might allow these ques-
tions to be addressed over time during
latent and reactivating infection.
This report addresses mechanisms of
MCMV pathogenesis in the host by crea-
tive application of tissue-specific recom-
bination, an approach that is likely to see
expanded use in this and other nuclear-
replicating DNA virus systems (SacherElsevier Inc.et al., 2008a). While the authors’ findings
alter the way we think about CMV dis-
ease, they are also a reminder to all
students of microbial pathogenesis: it
can be instructive to reexamine long-
held assumptions about the role of a given
host cell type in disease using the best
technologies available. Major sites of
replication may prove to be irrelevant in
subsequent steps of viral pathogenesis
and spread. In virology as in logic, post
hoc does not dictate ergo propter hoc!
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